Back to search
DS Stage I Plasma Cell Myeloma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which DS Stage I Plasma Cell Myeloma trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which DS Stage I Plasma Cell Myeloma trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This phase III trial compares the combination of four drugs (daratumumab, bortezomib, lenalidomide and dexamethasone) to the use of a three drug combination (da…
This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing s…
This randomized phase III trial studies lenalidomide to see how well it works compared to a placebo in treating patients with multiple myeloma who are undergoin…
This randomized phase III trial studies lenalidomide, dexamethasone, and bortezomib to see how well it works compared to dexamethasone and lenalidomide alone in…